Institute for Protein Design
Generated by GPT-5-miniExpansion Funnel Raw 103 → Dedup 0 → NER 0 → Enqueued 0
| Institute for Protein Design | |
|---|---|
| Name | Institute for Protein Design |
| Formed | 2012 |
| Type | Research institute |
| Headquarters | Seattle, Washington |
| Parent organization | University of Washington |
Institute for Protein Design is a research organization within the University of Washington devoted to de novo design of proteins for biomedical, industrial, and environmental applications. Founded in 2012, the institute integrates computational biology, structural biology, and synthetic biology to create novel proteins, collaborating with academic, governmental, and commercial partners. Its work intersects with infectious disease response, materials science, and therapeutics through design platforms and high-throughput experimental validation.
History
The institute was established in 2012 at the University of Washington with origins connected to laboratories led by David Baker and colleagues from the Department of Biochemistry and the Department of Genome Sciences. Early efforts built on methods developed at the Rosetta Commons, including collaborations with researchers from Carnegie Mellon University, Massachusetts Institute of Technology, Harvard University, California Institute of Technology, and University of California, San Francisco. Initial milestones included structural design projects linked to work by teams at the Broad Institute, Seattle Children's Research Institute, Fred Hutchinson Cancer Center, and the Allen Institute for Brain Science. Funding and recognition came from agencies and organizations such as the National Institutes of Health, Defense Advanced Research Projects Agency, National Science Foundation, Gates Foundation, and Chan Zuckerberg Initiative.
Mission and Research Focus
The institute’s mission emphasizes design of novel proteins to address challenges in infectious disease response, therapeutics development, and materials science applications, aligning with strategic goals from funders like the Wellcome Trust and the Howard Hughes Medical Institute. Research priorities include computational design, structural characterization, antigen design for vaccine research, enzymatic redesign, and molecular assembly, often coordinated with laboratories at Stanford University, Yale University, Princeton University, University of California, Berkeley, and Imperial College London. Projects frequently intersect with global health initiatives involving the Centers for Disease Control and Prevention, the World Health Organization, and regional institutions such as Seattle Biomedical Research Institute and University of Washington Medicine.
Key Technologies and Methods
Core technologies include the Rosetta (software) suite developed by members of the Rosetta Commons and high-throughput techniques such as yeast display and deep sequencing used in laboratories at MIT Broad Institute, Wellcome Sanger Institute, and Cold Spring Harbor Laboratory. Computational pipelines integrate algorithms from collaborations with teams at Google DeepMind, Microsoft Research, OpenAI, DeepGenomics, and academic groups at ETH Zurich and Max Planck Institute for Developmental Biology. Structural methods employ cryo-electron microscopy from centers like EMBL-EBI and cryo-EM facilities at the University of Washington, X-ray crystallography common at Argonne National Laboratory, and nuclear magnetic resonance supported by facilities at University of Cambridge. Synthetic biology workflows link to resources at Addgene, Ginkgo Bioworks, and Twist Bioscience.
Major Projects and Achievements
Notable achievements include design of stabilized viral antigens relevant to vaccine initiatives partnering with teams at Pfizer, Moderna, AstraZeneca, and academic collaborators at Johns Hopkins University, Columbia University, and University of Oxford. The institute contributed to rapid-response design efforts during outbreaks with coordination involving the National Institutes of Health, DARPA, and the Biomedical Advanced Research and Development Authority. De novo designed protein assemblies have been published alongside work by groups at Caltech, ETH Zurich, University of Toronto, and UCSF. High-impact demonstrations of designed enzymes and binders were presented in cooperation with researchers from Rockefeller University, Weill Cornell Medicine, McGill University, and University of Melbourne. Technology transfer and start-up formation included ventures linked to Seed Round investors, corporate partners like Amgen, and biotechnology incubators such as Johnson & Johnson Innovation and Flagship Pioneering.
Collaborations and Partnerships
The institute maintains collaborations with universities and research centers including Harvard Medical School, Stanford Medicine, Yale School of Medicine, Princeton Plasma Physics Laboratory, Salk Institute, Weizmann Institute of Science, University of Tokyo, Seoul National University, Peking University, Tsinghua University, and national laboratories such as Lawrence Berkeley National Laboratory and Argonne National Laboratory. Partnerships extend to pharmaceutical companies like Gilead Sciences, Roche, Novartis, and non-profit organizations including Bill & Melinda Gates Foundation and PATH. Consortia participation includes membership in the Rosetta Commons and joint programs with the Chan Zuckerberg Initiative and public health entities like the World Health Organization.
Organization and Leadership
Leadership has included scientists associated with the University of Washington faculty and principal investigators drawn from Department of Biochemistry and Department of Genome Sciences; notable affiliated researchers have published with colleagues at Harvard University, MIT, Caltech, Stanford University, Oxford University, Cambridge University, University College London, ETH Zurich, Max Planck Society, and Scripps Research. Administrative and translational roles coordinate with offices at the University of Washington Medical Center, technology transfer through the University of Washington CoMotion, and legal/ethical oversight involving groups like the National Academy of Sciences and National Academy of Medicine.
Education and Outreach
Educational programs connect to graduate training at the University of Washington, postdoctoral fellowships co-sponsored with Harvard University, summer internships in partnership with Cold Spring Harbor Laboratory and the Jackson Laboratory, and workshops with societies such as the American Society for Biochemistry and Molecular Biology, Biophysical Society, American Association for the Advancement of Science, and the International Union of Biochemistry and Molecular Biology. Public engagement includes seminars with the Seattle Science Festival, talks at institutions like the Pacific Science Center, and collaborative curricula developed with regional school districts and museums including the Seattle Museum of Flight.